ZBH Earnings & Financial Statements
Zimmer Biomet Holdings, Inc.
$91.77
-$0.31(-0.34%)
59
Overall
95
Value
27
Tech
57
Quality
Market Cap
$17.56B
Volume
1.89M
52W Range
$79.12 - $106.88
Target Price
$105.29
ZBH earnings and financial statements: Zimmer Biomet Holdings, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ZBH Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B |
| Cost of revenue | $2.49B | $2.19B | $2.08B | $2.02B | $1.96B |
| Operating income | $1.10B | $1.29B | $1.28B | $696.30M | $860.30M |
| EBITDA | $2.22B | $2.25B | $2.22B | $1.49B | $1.65B |
| Net income | $705.10M | $903.80M | $1.02B | $231.40M | $401.60M |
| EPS (diluted) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $23.09B | $21.37B | $21.50B | $21.07B | $23.46B |
| Total liabilities | $10.39B | $8.89B | $9.01B | $9.04B | $10.79B |
| Shareholders’ equity | $12.70B | $12.47B | $12.48B | $12.02B | $12.66B |
| Cash and equivalents | $591.90M | $525.50M | $415.80M | $375.70M | $378.10M |
| Long-term debt | $6.93B | $5.34B | $4.87B | $5.15B | $5.46B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $1.70B | $1.50B | $1.58B | $1.28B | $1.40B |
| Capital expenditure | -$276.90M | -$356.80M | -$394.50M | -$217.60M | -$152.00M |
| Free cash flow | $1.42B | $1.14B | $1.19B | $1.07B | $1.35B |
| Dividends paid | $190.30M | $196.00M | $200.90M | $201.20M | $200.10M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ZBH | $91.77 | -0.3% | 1.89M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Zimmer Biomet Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW